Directory People Institutions Residency Fellowship Interview prep

Overview
People
Events
Programs
Institutions
Specialties

Carlo Med
/
Directory
/
people
/
Benjamin Clayton

BC

Benjamin Clayton

Loading profile details

Carlo med

Medical training, understood.

Part of the Carlo family

© 2026 Carlo Finance, Inc.

Methodology Privacy People

Journey Education Research Sources

About

Case Western Reserve University postdoctoral researcher to lead MS study with new career transition fellowship from National Multiple Sclerosis Society | School of Medicine | School of Medicine | Case Western Reserve University

a $550,000 Career Transition Fellowship to lead the study

Training

Training history is being assembled from public sources.

Explore education and training

Research

Explore attributed publications and documented research affiliations.

Explore research

Education and career

Reviewed Sep 9, 2026

Professional role

postdoctoral researcher[1]

Research

Loading projects and selected reading

Publications

Loading research summary

Loading publications

[data-research-loading]{display:none!important}Browse publications

Sources

Sources are listed once and connected to each accepted claim they support. Excerpts preserve the source language used in the review.

[1]
Case Western Reserve University postdoctoral researcher to lead MS study with new career transition fellowship from National Multiple Sclerosis Society | School of Medicine | School of Medicine | Case Western Reserve University
3 source claims · Reviewed Sep 9, 2026
Biographical context: a $550,000 Career Transition Fellowship to lead the study
Benjamin Clayton NMSS awarded Benjamin Clayton, a postdoctoral researcher in the lab of Paul Tesar, the Dr. Donald and Ruth Weber Goodman Professor of Innovative Therapeutics at the School of Medicine, a $550,000 Career Transition Fellowship to lead the study.
Identity: Benjamin Clayton
Benjamin Clayton NMSS awarded Benjamin Clayton, a postdoctoral researcher in the lab of Paul Tesar, the Dr. Donald and Ruth Weber Goodman Professor of Innovative Therapeutics at the School of Medicine, a $550,000 Career Transition Fellowship to lead the study.
Professional role: postdoctoral researcher
NMSS awarded Benjamin Clayton, a postdoctoral researcher in the lab of Paul Tesar, the Dr. Donald and Ruth Weber Goodman Professor of Innovative Therapeutics at the School of Medicine, a $550,000 Career Transition Fellowship to lead the study.
Benjamin Clayton NMSS awarded Benjamin Clayton, a postdoctoral researcher in the lab of Paul Tesar, the Dr. Donald and Ruth Weber Goodman Professor of Innovative Therapeutics at the School of Medicine, a $550,000 Career Transition Fellowship to lead the study.